PCSK9 and ovarian carcinoma: However, PCSK9 exhibited a protective effect in two other cancer types, brain cancer [OS: total = 67, HR = 0.01, Cox p = 0.030] and ovarian cancer [PFS (progression free survival): total = 110, HR = 0.89, Cox p = 0.044] (Figure 3A).